Missing: MyClinic's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: MyClinic's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing MyClinic
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned MyClinic in 1 CB Insights research brief, most recently on May 6, 2021.
Expert Collections containing MyClinic
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MyClinic is included in 2 Expert Collections, including Telehealth.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest MyClinic News
Apr 12, 2021
Image: HealthHero This latest deal follows its takeover of Dublin’s MyClinic in January and Doctorlink in December as it rapidly expands in Europe. British telehealth company HealthHero is start-up shopping once again, this time acquiring French player Qare. The deal sees HealthHero expand further into the European market after it acquired Ireland’s MyClinic in January. No financial terms for the deal were disclosed. Qare, based in Paris, provides a platform for medical consultations through video. It was backed by Kamet Ventures, a specialist investment firm targeting health and insurance start-ups. Last year, Qare acquired mental health start-up Doctopsy. “This is the most significant telehealth acquisition in Europe in recent times, and firmly secures HealthHero’s dominance in the growing telehealth sector, in the largest healthcare market in the world,” HealthHero chief executive Ranjan Singh said. According to HealthHero, it provides 3m consultations a year and will have a revenue run rate of €100m this year. Olivier Thierry, Qare’s CEO, will remain in the company, taking on a senior management role at HealthHero. “Europe is seeing an explosion of telehealth businesses. We are convinced that tomorrow’s health tech champions will be European. We share with HealthHero a common European vision for quality and innovative care accessible to all, powered by technology,” Thierry said. Stephane Guinet of Kamet Ventures, the principle investor in Qare, said the company was founded to “empower patients by offering them access to a holistic set of personalised medical services that were previously only available in-person”. HealthHero now has operations in the UK, Ireland, Germany and France. It entered the Irish market in January with its acquisition of Dublin start-up MyClinic, an app for digital consultations and managing prescriptions. The company said it is pursuing a multi-pronged business model with services for consumers, businesses and government. HealthHero is headed up by Singh, whose investment firm Marcol is the main backer of the start-up. It is growing heavily through acquisitions having also acquired Doctorlink, another UK start-up, late last year.
MyClinic Frequently Asked Questions (FAQ)
Where is MyClinic's headquarters?
MyClinic's headquarters is located at 3 Terenure Road West, Dublin 6.
What is MyClinic's latest funding round?
MyClinic's latest funding round is Acquired.
Who are the investors of MyClinic?
Investors of MyClinic include HealthHero .
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.